drugset / Trial / NCT00973102
Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)
Phase 2
Completed
50 enrolled
University of Texas Southwestern Medical Center
Resuscitation Outcomes Consortium · collabUniversity of Washington · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Based on encouraging results from animal studies, the investigators hypothesize that early administration of IV Premarin® in patients with hemorrhagic shock will safely reduce secondary injury, and improve survival.
Timeline
- Start
- 2009-07
- Primary completion
- 2012-01
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | conjugated estrogens | Other / unclassified | 0.5 mg/kg | Intravenous |
Indications
No indication recorded.